In the SERBP1-knockdown NASH mouse model, the degree of hepatic steatosis is reduced by 60%, and the expression of inflammatory factors (TNF-α and IL-6) is decreased by 45%, confirming the pro-pathological role of SERBP1 in NASH [36]. Here, SERBP1 is linked to metabolic dysfunction-associated steatohepatitis.